Global Bacteriophage Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Agriculture
Publisher : MRA | Format : PDF
Global Bacteriophage Sales Market Report 2024
Market Analysis and InsightsGlobal Bacteriophage Market
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Due to the COVID-19 pandemic, the global Bacteriophage market size is estimated to be worth US$ 32 million in 2022 and is forecast to a readjusted size of US$ 102.6 million by 2033 with a CAGR of 17.9% during the forecast period 2023-2033. Fully considering the economic change by this health crisis, DsDNA Bacteriophage accounting for % of the Bacteriophage global market in 2022, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Animal Health segment is altered to an % CAGR throughout this forecast period.
The United States is the largest consumer market, accounting for about 38%, and Europe is the second largest market, accounting for about 26%.
The market for Bacteriophage is fragmented with players such as NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS) , Qingdao Phagepharm Bio-tech,. Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage and so on. Among them, the top 5 manufacturers with about 34% revenue market share.
Global Bacteriophage Scope and Market Size
The global Bacteriophage market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bacteriophage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2033.
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
Due to the COVID-19 pandemic, the global Bacteriophage market size is estimated to be worth US$ 32 million in 2022 and is forecast to a readjusted size of US$ 102.6 million by 2033 with a CAGR of 17.9% during the forecast period 2023-2033. Fully considering the economic change by this health crisis, DsDNA Bacteriophage accounting for % of the Bacteriophage global market in 2022, is projected to value US$ million by 2033, growing at a revised % CAGR from 2023 to 2033. While Animal Health segment is altered to an % CAGR throughout this forecast period.
The United States is the largest consumer market, accounting for about 38%, and Europe is the second largest market, accounting for about 26%.
The market for Bacteriophage is fragmented with players such as NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC, Pherecydes Pharma, APS Biocontrol Ltd. (APS) , Qingdao Phagepharm Bio-tech,. Fixed-Phage Limited, Zeptometrix, Phage International, Inc., MicroMir, iNtODEWORLD, Inc., NEXTBIOTICS, Armata Pharmaceuticals, Inc., Innophage and so on. Among them, the top 5 manufacturers with about 34% revenue market share.
Global Bacteriophage Scope and Market Size
The global Bacteriophage market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bacteriophage market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2033.
Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage